TCL Archive Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma January 30, 2009
TCL Archive NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units March 1, 2013
TCL Archive NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization June 22, 1990
TCL Archive Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors. June 17, 2005
